Posted inNews and Updates
FDA Approves Denifanstat Phase 3 Trials for Severe Acne
The FDA has greenlit Phase 3 trials for denifanstat, a novel FASN inhibitor targeting moderate to severe acne. Learn how this treatment could redefine care.
Posted inNews and Updates
Uttar Pradesh Unveils 2023 Pharma & Medical Device Policy
Discover how the Uttar Pradesh Pharma and Medical Device Policy 2023 is set to transform the state into a global hub for healthcare manufacturing.
Posted inNews and Updates
Metaberine Study: New Findings on Metabolic Health Support
New clinical findings show Metaberine® improves metabolic health markers at a 200 mg daily dose. Learn how this breakthrough supports metabolic wellness.
Posted inNews and Updates
BathMat Trial: New Approach to Reducing ICU Workload
The BathMat trial reveals how updated ICU bathing protocols can lower staff burnout, reduce nursing workload, and improve outcomes for critically ill patients.
Posted inNews and Updates
Zipalertinib Shows Promise in First-Line NSCLC Treatment
Zipalertinib combination therapy meets key PFS endpoints in first-line EGFR exon 20 NSCLC, marking a major advancement in targeted lung cancer treatment.
Posted inNews and Updates
Definium’s DT120 Succeeds in Phase 3 Anxiety Study
Definium’s DT120 shows significant success in a Phase 3 anxiety trial, meeting primary endpoints and offering hope for new, effective GAD treatment options.
Posted inNews and Updates
Generative AI in Clinical Trials: Market Growth to 2035
Discover how Generative AI is reshaping the clinical trials market, with projections hitting USD 1,986 billion by 2035. Learn about its impact on drug R&D.
Posted inNews and Updates
How the CoMMpass Study is Reshaping Myeloma Treatment
Explore how the landmark CoMMpass Study is transforming multiple myeloma care through genomic profiling, targeted therapies, and personalized medicine.
Posted inNews and Updates
AI Boosts Drug Development by $21M Per Program
New research shows AI integration can slash drug development costs by $21M per program. Discover how machine learning is transforming pharmaceutical R&D.
Posted inNews and Updates
AI and Health Networks Revolutionize Clinical Trial Access
Discover how AI and digital health networks are breaking down barriers to clinical trials, improving patient recruitment, and accelerating medical research.